Search Results 2451-2460 of 18236 for rheumatoid arthritis

  1. Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis - Mayo Clinic

    Participation eligibility · Men or women aged 18 years and older · Systemic sclerosis, as defined by ACR/EULAR (American College of Rheumatology/European League ...

  2. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... factor agents) within 2 weeks prior to the first dose of study treatment; any other anti-cancer therapy, whether investigational or approved, including but ...

  3. Cold hands - Mayo Clinic

    National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/scleroderma. Accessed Feb. 29, 2024. Varga J ...

  4. Publications - Katie N. Hunt, M.D. - Mayo Clinic

    ... factor: a case-control study. Breast Cancer Res. 2016 Apr 26; 18 (1):42. View PubMed; Conners AL, Jones KN, Hruska CB, Geske JR, Boughey JC, Rhodes DJ. Direct ...

  5. Postoperative Infections Clinical Trials

    ... Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of ...

  6. Mayo Clinic-led study open for enrollment: Prehabilitation for patients receiving radiotherapy and surgery for soft tissue sarcoma

    One factor in customization is tumor location. Each participant will have weekly in-person meetings for prehabilitation during neoadjuvant radiotherapy ...

  7. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

    * A clinical diagnosis of SLE, based on the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for ...

  8. Technical Reports - Department of Quantitative Health Sciences - Mayo Clinic Research

    Population attributable risk (PAR) is a function of time because both the prevalence of a risk factor and its effect on exposed individuals may change over ...

  9. Rotator Cuff Injury Clinical Trials - Mayo Clinic Research

    ... arthritis. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site Map · About This Site. Legal Conditions and ...

  10. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Mayo Clinic Researchers Link Senescent Cells to Most Common Form of Arthritis featured image · Discovery's Edge: New Stents for Complex Aortic ...